Suchergebnisse - "Bays, Harold E"

PubPharm (248)

1

Author Correction : The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial

enthalten in: Nature medicine | 2024

von Bhatt, D. | Bays, H. | Miller, M. | +12

ErratumFor: Nat Med. 2023 Jul;29(7):1782-1792. - PMID 37355760

2

Safety of bempedoic acid in patients at high cardiovascular risk and with statin intolerance

enthalten in: Journal of clinical lipidology | 2024

von Bays, H. | Bloedon, L. | Lin, G. | +5

3

Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity : The SURMOUNT-4 Randomized Clinical Trial

enthalten in: JAMA | 2024

von Aronne, L. | Sattar, N. | Horn, D. | +85

4

Effects of phentermine / topiramate extended-release, phentermine, and placebo on ambulatory blood pressure monitoring in adults with overweight or obesity : A randomized, multicenter, double-blind study

enthalten in: Obesity Pillars (Online) | 2024

von Bays, H. | Hsia, D. | Nguyen, L. | +2

5

The FGF21 analog pegozafermin in severe hypertriglyceridemia : a randomized phase 2 trial

enthalten in: Nature medicine | 2023

von Bhatt, D. | Bays, H. | Miller, M. | +12

ErratumIn: Nat Med. 2024 Mar 4;:. - PMID 38438737

6

Bempedoic acid lowers high-sensitivity C-reactive protein and low-density lipoprotein cholesterol : Analysis of pooled data from four phase 3 clinical trials

enthalten in: Atherosclerosis | 2023

von Stroes, E. | Bays, H. | Banach, M. | +8

7

Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients

enthalten in: The New England journal of medicine | 2023

von Nissen, S. | Lincoff, A. | Brennan, D. | +127

CommentIn: Nat Rev Cardiol. 2023 May;20(5):285. - PMID 36944785

8

Corrigendum to "Anti-Obesity Medications and Investigational Agents : An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022" [Obes Pillars 2 (2022) 100018

enthalten in: Obesity Pillars (Online) | 2022

von Bays, H. | Fitch, A. | Christensen, S. | +2

9

Factors Associated With Enhanced Low-Density Lipoprotein Cholesterol Lowering With Bempedoic Acid

enthalten in: Journal of the American Heart Association | 2022

von Ballantyne, C. | Bays, H. | Louie, M. | +3

10

Long-Term Safety and Efficacy of Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from the CLEAR Harmony Open-Label Extension Study)

enthalten in: The American journal of cardiology | 2022

von Ballantyne, C. | Banach, M. | Bays, H. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]